Näytetään tulokset 1 - 10 / 313
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Incidence of myelodysplastic syndromes in Finland 1997-2016

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.leukres.2022.106839
Kontro, Suvi; Raitanen, Jani; Porkka, Kimmo; Auvinen, Anssi
Leukemia research2022

miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation

Vertaisarvioitu
DOI
10.3109/10428194.2011.568652
Borze, Ioana; Scheinin, Ilari; Siitonen, Sanna; Elonen, Erkki; Juvonen, Eeva; Knuutila, Sakari
Leukemia & lymphoma2011

Acquired Somatic Mutations in T Cells in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndromes

Vertaisarvioitu
Lundgren, Sofie; Keränen, Mikko; Nousiainen, Kari; Eldfors, Samuli; Hannula, Sari; Hannunen, Tiina; ...
Blood2017

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation:a retrospective study of the MDS subcommittee of the CMWP of the EBMT

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00277-016-2802-z
Cremers, E. M. P.; van Biezen, A.; de Wreede, L. C.; Scholten, M.; Vitek, A.; Finke, J.; Platzbecker...
Annals of hematology2016

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia

Avoin saatavuus
DOI
10.3324/haematol.2014.118034
Karimi, Mohsen; Nilsson, Christer; Dimitriou, Marios; Jansson, Monika; Matsson, Hans; Unneberg, Per;...
Haematologica2015

Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic synd

Vertaisarvioitu
Avoin saatavuus
DOI
10.3324/haematol.2014.116715
Koenecke, Christian; Goehring, Gudrun; de Wreede, Liesbeth C.; van Biezen, Anja; Scheid, Christof; V...
Haematologica: the hematology journal2015

Structural Variant Analysis of Complex Karyotype Myelodysplastic Neoplasia Through Optical Genome Mapping

Vertaisarvioitu
DOI
10.1002/gcc.70024
Valkama, Andriana; Vorimo, Sandra; Tervasmäki, Anna; Räsänen, Hannele; Savolainen, Eeva-Riitta; Pylk...
Genes chromosomes and cancer2025

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41375-018-0302-y
Schetelig, Johannes; de Wreede, Liesbeth C.; van Gelder, Michel; Koster, Linda; Finke, Jürgen; Niede...
Leukemia2019

"Randomized phase II study of azacitidine +/- lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

Avoin saatavuus
DOI
10.1038/s41375-022-01537-w
Rasmussen, Bengt; Gohring, Gudrun; Bernard, Elsa; Nilsson, Lars; Tobiasson, Magnus; Jadersten, Marti...
Leukemia2022

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/10428194.2019.1594215
Cremers, Eline M. P.; de Witte, Theo; de Wreede, Liesbeth; Eikema, Diderik-Jan; Koster, Linda; van B...
Leukemia & lymphoma2019

Incidence of myelodysplastic syndromes in Finland 1997-2016

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.leukres.2022.106839
2022

miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation

Vertaisarvioitu
DOI
10.3109/10428194.2011.568652
2011

Acquired Somatic Mutations in T Cells in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndromes

Vertaisarvioitu
2017

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation:a retrospective study of the MDS subcommittee of the CMWP of the EBMT

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00277-016-2802-z
2016

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia

Avoin saatavuus
DOI
10.3324/haematol.2014.118034
2015

Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic synd

Vertaisarvioitu
Avoin saatavuus
DOI
10.3324/haematol.2014.116715
2015

Structural Variant Analysis of Complex Karyotype Myelodysplastic Neoplasia Through Optical Genome Mapping

Vertaisarvioitu
DOI
10.1002/gcc.70024
2025

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41375-018-0302-y
2019

"Randomized phase II study of azacitidine +/- lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

Avoin saatavuus
DOI
10.1038/s41375-022-01537-w
2022

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/10428194.2019.1594215
2019